Bin Liu

Bin Liu is a Professor in the Department of Anesthesia at the University of California, San Francisco, with a focus on antibody-drug conjugates (ADCs) and theranostics for oncology. His work spans prostate cancer, multiple myeloma, and radiopharmaceutical therapies, often involving CD46-targeted approaches. He has contributed to the development of synNotch CAR circuits and nanoliposomal drug formulations.

• Pharmacokinetics of ciprofol, voriconazole, and other drugs in diverse populations.
• Drug interactions involving CYP enzymes, P-gp, and BCRP transporters.
• Theranostic agents for imaging and alpha therapy in cancer.

His research integrates translational oncology with pharmacological modeling, including PBPK and population pharmacokinetic studies. Articles highlight collaborations with groups at UCSF, with co-senior authorships on studies of 225Ac-radioimmunotherapy and CD46 biology. No formal scientific awards are explicitly listed in the provided texts.